Neutralization Antibody Panel

Detect COVID-19 Binding Antibodies and Quantify COVID-19 Neutralizing Antibodies

The only FDA EUA Approved Panel
now with 24 HR Reporting

The Neutralization Antibody (NAbs) Panel is an extremely useful, first-of-its-kind diagnostic test that facilitates the specific detection of IgG, IgM and quantitation of neutralizing antibodies (NAbs) against SARS-CoV-2. NAbs are a subset of IgG, IgM and IgA antibodies involved in key immune responses to shield cells from the virus, preventing infection propagation. Past COVID-19 infections can be detected from a qualitative binding IgG and IgM test.

Screen Shot 2021-08-10 at 1.58.17 PM

The Neutralization Antibody Panel quickly and accurately detects and measures neutralization response in a sample against the SARS-CoV-2 virus.

GET STARTED NOW
featured-shot-vaccine-provista2

Detecting IgG / IgA / IgM does NOT mean one has infection blocking NAbs!

cPass™ First-in-the-World Neutralizing Antibody Panel

effective-vaccine-1278870086

Vaccine Efficacy

Therapy

Therapy Validation

cPass™ Key Benefits

iStock-931409422-sm

FDA EUA Approved

Authorized for
Emergency Use

iStock-1055996940-web

Sensitive & Specific

100% Positive &
100% Negative

hero-test-tubes-provista3

Safe & Scalable

Easier and Readily Automatable

blood-vial-with-test-results

Quantifies

Measure and Track
Levels Over Time

The cPass test is faster, easier, more scalable, and readily automatable compared to the traditional neutralizing antibody tests, such as virus neutralization test (VNT), pseudo-virus neutralization test (pVNT), and plaque reduction neutralization test (PRNT).

Reducing the Chromogenic Reaction

The panel contains two key components: the Horseradish peroxidase (HRP) conjugated recombinant SARS-CoV-2 RBD fragment (HRP-RBD) and the human ACE2 receptor protein (hACE2).

The SARS-CoV-2 sVNT Kit is a blocking ELISA detection tool, which mimics the virus neutralization process. The test uses the interaction between viral protein-receptor protein to mimic the virus infection of a live cell, which is monitored by a chromogenic reaction. When there are neutralizing antibodies in the patient sera, they will block the specific protein-protein interaction and hence reducing the chromogenic reaction, mimicking the virus neutralization process.

featured-shot-vaccine-provista1

Start detecting COVID-19 Neutralizing Antibodies.

Get the vital data your patients need today

Stay informed of our latest breakthroughs.